Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trialSmith-Apeldoorn, S. Y., Veraart, J. K. E., Kamphuis, J., van Asselt, A. D. I., Touw, D. J., Aan Het Rot, M. & Schoevers, R. A., 8-Jan-2020, In : BMC Psychiatry. 20, 1, 1 p., 9.
Research output: Contribution to journal › Article › Academic › peer-review
- Value, Affordability and Sustainability (VALUE)
- PharmacoTherapy, Epidemiology and Economics
- Pharmacoepidemiology and Pharmacoeconomics
- Pharmaceutical Analysis
- Critical care, Anesthesiology, Peri-operative and Emergency medicine (CAPE)
- Groningen Research Institute for Asthma and COPD (GRIAC)
- Biopharmaceuticals, Discovery, Design and Delivery (BDDD)
- Pharmacokinetics, Toxicology and Targeting
- Clinical Psychology and Experimental Psychopathology
- Perceptual and Cognitive Neuroscience (PCN)
- Interdisciplinary Centre Psychopathology and Emotion regulation (ICPE)
After publication of our article  we were notified that Figure 1 was wrongly presented.
|Number of pages||1|
|Publication status||Published - 8-Jan-2020|